|
Name |
2-Decanone
|
Molecular Formula | C10H20O | |
IUPAC Name* |
decan-2-one
|
|
SMILES |
CCCCCCCCC(=O)C
|
|
InChI |
InChI=1S/C10H20O/c1-3-4-5-6-7-8-9-10(2)11/h3-9H2,1-2H3
|
|
InChIKey |
ZAJNGDIORYACQU-UHFFFAOYSA-N
|
|
Synonyms |
2-Decanone; Decan-2-one; 693-54-9; METHYL OCTYL KETONE; Methyl n-octyl ketone; Octyl methyl ketone; n-C8H17COCH3; GX543OLT0R; CHEMBL47127; CHEBI:77929; 2-Decanone, >=98%; EINECS 211-752-6; UNII-GX543OLT0R; BRN 1747463; MFCD00009571; 2-Decanone, 98%; DSSTox_CID_2104; 2-DECANONE [FHFI]; DSSTox_GSID_22104; 4-01-00-03367 (Beilstein Handbook Reference); SCHEMBL103053; 2-Decanone, analytical standard; DTXSID9022104; FEMA NO. 4271; ZINC2031407; Tox21_303799; BDBM50409665; LMFA12000044; AKOS009158912; NCGC00357084-01; AS-56271; CAS-693-54-9; DB-003265; D1643; FT-0612135; D89897; EN300-170618; A836446; Q20054515
|
|
CAS | 693-54-9 | |
PubChem CID | 12741 | |
ChEMBL ID | CHEMBL47127 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 156.26 | ALogp: | 3.7 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.507 |
Caco-2 Permeability: | -4.462 | MDCK Permeability: | 0.00001730 |
Pgp-inhibitor: | 0.081 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.992 |
30% Bioavailability (F30%): | 0.992 |
Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 92.00% |
Volume Distribution (VD): | 0.849 | Fu: | 8.81% |
CYP1A2-inhibitor: | 0.901 | CYP1A2-substrate: | 0.789 |
CYP2C19-inhibitor: | 0.491 | CYP2C19-substrate: | 0.607 |
CYP2C9-inhibitor: | 0.32 | CYP2C9-substrate: | 0.93 |
CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.445 |
CYP3A4-inhibitor: | 0.044 | CYP3A4-substrate: | 0.119 |
Clearance (CL): | 6.51 | Half-life (T1/2): | 0.69 |
hERG Blockers: | 0.08 | Human Hepatotoxicity (H-HT): | 0.021 |
Drug-inuced Liver Injury (DILI): | 0.106 | AMES Toxicity: | 0.006 |
Rat Oral Acute Toxicity: | 0.037 | Maximum Recommended Daily Dose: | 0.032 |
Skin Sensitization: | 0.662 | Carcinogencity: | 0.094 |
Eye Corrosion: | 0.987 | Eye Irritation: | 0.969 |
Respiratory Toxicity: | 0.208 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000265 | 0.909 | D0E4WR | 0.444 | ||||
ENC000454 | 0.900 | D0Z5BC | 0.435 | ||||
ENC000556 | 0.833 | D0XN8C | 0.391 | ||||
ENC000254 | 0.800 | D03ZJE | 0.391 | ||||
ENC000399 | 0.769 | D07ILQ | 0.385 | ||||
ENC000263 | 0.714 | D0AY9Q | 0.385 | ||||
ENC000250 | 0.700 | D05ATI | 0.375 | ||||
ENC000642 | 0.667 | D0O1PH | 0.352 | ||||
ENC000088 | 0.658 | D0FD0H | 0.350 | ||||
ENC000722 | 0.658 | D0O1TC | 0.348 |